SMN1 and proximal spinal muscular atrophy: The diagnosis of SMA can be confirmed with molecular genetic testing with targeted mutation analysis [10] because mutations in the SMN1 gene cause spinal muscular atrophy (SMA), a disorder characterized by progressive symmetric muscle weakness that can be complicated by other features, including joint contractures, scoliosis, growth failure, and restrictive lung disease.